ProductsDistribution Products

LAMZEDE

Therapeutic indication:

Enzyme replacement therapy for the treatment of non-neurological manifestations in patients with mild to moderate alpha-mannosidosis.

  • Composition: Velmanase Alfa 10 mg/vial
  • Pharmaceutical form: Powder for solution for infusion, white to off-white powder
  • Method of administration: Intravenous infusion
  • Manufacturer: Chiesi